CFO Service AgreementCfo Service Agreement • September 29th, 2017 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
DanDrit Biotech A/S CVR No 26 02 73 22 c/o Symbion Science Park Fruebjergvej 3 2100 Copenhagen Denmark (hereinafter referred to as the ”Company”)
CFO SERVICE AGREEMENT between DanDrit Biotech A/S CVR No 26 02 73 22 c/o Symbion Science Park Fruebjergvej 3 (hereinafter referred to as the "Company") and Robert E. Wolfe PO Box 189 Randolph, VT 05060 (hereinafter referred to as the "CFO")Cfo Service Agreement • June 23rd, 2014 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
AMENDMENT NO. 1 TO CFO SERVICE AGREEMENTCfo Service Agreement • February 9th, 2018 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this “Amendment”) to the CFO Service Agreement dated June 30, 2017 (the “Agreement”) is entered into as of December 29, 2017 (the “Effective Date”), by and among DANDRIT BIOTECH BIOTECH A/S., CVR no. 26 02 73 22, a Denmark corporation (the “Company”) and the Crossfield, Inc., Robert E. Wolfe (the “Consultant” and together with the Company, the “Parties”). Capitalized terms not Defined herein shall have the meaning set forth in the Agreement.
